| 6:45 a.m. |
Registration |
| 7:30 a.m. |
Introduction by Moderators |
| 7:35 a.m. |
2021 Harry Hirsch Leiter Award Recipient:
Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II)
Hamidah Mahmud, BA, MPhil |
| 7:42 a.m. |
1. One-Year Clinical and Patient-Reported Outcomes of Corneal Neurotization Surgery and Cenegermin Therapy in Neurotrophic Keratopathy
Hazem M. Mousa, MD |
| 7:49 a.m. |
2. A 20-year Retrospective Analysis of Methicillin and Moxifloxacin Susceptibility among Staphylococcus aureus Keratitis Isolates
Eric G. Romanowski, MS |
| 7:56 a.m. |
3. Genomic Epidemiology and Antimicrobial Resistance of MRSA Isolates Causing Keratitis
Camille Andre |
| 8:03 a.m. |
4. A Four-Year Review of the Epidemiology, Risk Factors, Treatment, and Outcomes for Corneal Ulcers at a Tertiary Referral Center in New Jersey
Ava Torjani, BS |
| 8:10 a.m. |
5. A Metagenomic Deep Sequence Analysis of Infectious Conjunctivitis Etiology in Burkina Faso, Africa and Berkeley, California
Gerami D. Seitzman, MD |
| 8:17 a.m. |
6. Efficacy of Ophthalmic Antimicrobials in Combination Therapeutic Approaches
Rachel AF Wozniak, MD, PhD |
| 8:24 a.m. |
7. Inflammasomes Expressed in Corneal Epithelial Cells are Targets of Pseudomonas aeruginosa Exotoxin S
Abby R. Kroken, PhD
|
| 8:31 a.m. |
8. Ocular Tissue Diagnosis and Drug Susceptibility Testing of Extensively Drug-Resistant Tuberculosis
Sanchita Mitra, MD |
| 8:38 a.m. |
9. Validation of the C-DU(KE) Calculator as a Predictor of Outcomes in Patients Enrolled in SCUT and MUTT Trials
Alejandro Arboleda |
| 8:45 a.m. |
10. Development and Validation of a Multilabel Computer Vision Model for Identification of Bacterial and Fungal Keratitis in a Prospectively Collected Dataset
Travis K. Redd, MD, PhD |
| 8:52 a.m. |
11. Ocular Microbiome…. Dead on Arrival?
Darlene Miller, DHSc |
| 8:59 a.m. |
OPEN QUESTIONS AND COMMENTS |
| |
BREAK |
| 9:15 a.m. |
12. Fungal Keratitis in Pittsburgh: Clinical Features, Risk Factors, Treatment, and Outcomes
Sarah Atta |
| 9:22 a.m |
13. Fusarium keratitis in South Florida: A Clinico-Microbiological Correlation
Paula A. Sepulveda-Beltran, MD, and Piero Carletti, BS |
| 9:29 a.m. |
14. Genipin Corneal Crosslinking Treatment in a Fusarium solani Keratitis Model
Marcela Huertas-Bello |
| 9:36 a.m. |
15. Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) for Fungal Keratitis: A Pilot Case Series
Neel D. Pasricha, MD |
| 9:43 a.m. |
16. Evaluation of Rose Bengal, Erythrosin B, and Eosin Y for Photodynamic Antimicrobial Therapy Against Ocular Isolates
Katherine D. Leviste, MS |
| 9:50 a.m. |
17. Topical 2% Cyclosporine is Effective in Controlling the Inflammation and Improving the Treatment Outcome in Patients with Acanthamoeba Keratitis
Matteo Posarelli, MD |
| 9:57 a.m. |
18. Outcome of Photo Dynamic Antimicrobial therapy with Rose Bengal as an Aadjuvant Treatment in the Management of Acanthamoeba keratitis: Prospective Interventional Trial
Bhupesh Bagga, MD
|
| 10:04 a.m. |
19. Molecular and Histopathologic Correlation Between Acanthamoeba Species Recovered from Patients Who Underwent Therapeutic and Optical Penetrating Keratoplasties After Rose Bengal Photodynamic Antimicrobial Therapy
Sara Mustafa, MMS |
| 10:11 a.m. |
OPEN QUESTIONS AND COMMENTS |
| . |
BREAK |
| 10:30 a.m. |
20. Role of Topical 5-Fluorouracil in Management of Demodex-associated Blepharitis
Mona M. Amer, BA |
| 10:37 a.m. |
21. Busting Biofilms: A New Treatment for Blepharitis, Meibomian Gland Dysfunction and Dry Eye Syndrome
Richard A. Eiferman, MD, MBA |
| 10:44 a.m. |
22. Comparison between Neuropathic Corneal Pain and Dry Eye Disease in regards to Age and Gender Dependent Ompairment of Quality-of-Life Dimensions
Leyla Mirzaee, DMSc |
| 10:51 a.m. |
23. Impact of Tumor Necrosis Factor Receptor 1 (TNFR1) Polymorphism on Dry Eye Disease
Kelly Acuna, BS
|
| 10:58 a.m. |
24. Ocular Surface Inflammation and Dry Eye Symptoms at Day 100 Post-Transplantation Are Not Predictive Factors for The Development of Chronic Graft Versus Host Disease
Arianna Tovar, MD |
| 11:05 a.m. |
OPEN QUESTIONS AND COMMENTS |
| |
BREAK |
| 11:20 a.m. |
Thygeson Lecture:
"The Role of Photoactivated Chromophores in the Treatment of Infectious Keratitis?"
Dr. Ana Luisa Höfling-Lima
Professor of Ophthalmology
Escola Paulista de Medicina
Federal University of São Paulo
|
| 12:00 p.m. |
Closing Comments and Awards |
| 12:15 p.m. |
Business Luncheon |
